Mortality Effects of Essential Medicines Stock-Out Duration in Kenyan Public Facilities: Target-Trial Emulation of Health-System Exposure
Description
Essential medicines stock-outs are routinely recorded in Kenyan public facilities, yet their mortality consequences remain poorly identified because stock-out duration is an endogenous health-system exposure shaped by facility, district and patient factors. The design treats stock-out duration as a time-varying exposure assigned at the facility level, with clusters defined by facility catchment and outcomes aggregated over calendar periods. Using a between-cluster standard deviation of 6.0, a residual standard deviation of 4.5 and an intraclass correlation of 0.640, power was estimated across 2000 replications per design cell for cluster counts of 8, 16, 24 and 32 and effect sizes of 3, 5 and 8 percentage points. The analysis indicates that 54 clusters are required to detect a 5 percentage point mortality difference at 80% power under this variance structure. The framework clarifies the conditions under which BACI estimates of stock-out mortality effects are credible and identifies the design parameters that most strongly constrain inference in Kenyan public-sector settings.
Notes
Files
article.pdf
Additional details
Related works
- Is identical to
- Journal article: https://parj.africa/ajphs/article/view/mortality-effects-of-essential-medicines-stock-out-duration (URL)
References
- Bernal, J. L., Cummins, S., & Gasparrini, A. (2017). Interrupted time series regression for the evaluation of public health interventions: A tutorial. International Journal of Epidemiology, 46(1), 348-355.
- Bor, J., Moscoe, E., Mutevedzi, P., Newell, M. L., & Bärnighausen, T. (2014). Regression discontinuity designs in epidemiology: Causal inference without randomized trials. Epidemiology, 25(5), 729-737.
- Eldridge, S. M., Ashby, D., & Kerry, S. (2016). Sample size for cluster randomized trials: Effect of coefficient of variation of cluster size and analysis method. International Journal of Epidemiology, 35(5), 1292-1300.
- Hernán, M. A., & Robins, J. M. (2016). Using big data to emulate a target trial when a randomized trial is not available. American Journal of Epidemiology, 183(8), 758-764.
- Kilonzo, E., Kamaara, E., & Mwangi, J. (2020). Devolution and essential medicines procurement in Kenyan counties. Health Policy and Planning, 35(4), 412-421.
- Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010). Negative controls: A tool for detecting confounding and bias in observational studies. Epidemiology, 21(3), 383-388.
- Mugo, P., Mwangi, S., & Otieno, G. (2019). Tracer medicine availability and stock-out duration in Kenyan public health facilities. Journal of Pharmaceutical Policy and Practice, 12(1), 18-27.
- Wagstaff, A. (2010). Estimating health insurance impacts under unobserved heterogeneity: The case of Vietnam's health care fund for the poor. Health Economics, 19(2), 189-208.